title: Viral hepatitis at a crossroad.
authors.forename: Anna S F
authors.initials: AS
authors.lastname: Lok
authors.forename: Jean-Michel
authors.initials: JM
authors.lastname: Pawlotsky
mesh_terms: D000818:Animals; D000998:Antiviral Agents / Q000494:pharmacology / Q000627:therapeutic use; D035843:Biomedical Research / Q000639:trends*; D006528:Carcinoma, Hepatocellular / Q000175:diagnosis / Q000821:virology; D002471:Cell Transformation, Neoplastic; D017281:Cost of Illness; D004195:Disease Models, Animal; D024882:Drug Resistance, Viral; D016679:Genome, Viral; D014943:Global Health; D016174:Hepacivirus / Q000187:drug effects / Q000276:immunology; D006509:Hepatitis B / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology / Q000503:physiopathology / Q000517:prevention & control; D006515:Hepatitis B virus / Q000187:drug effects / Q000276:immunology; D006526:Hepatitis C / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology / Q000503:physiopathology / Q000517:prevention & control; D006801:Humans; D008103:Liver Cirrhosis / Q000821:virology; D008113:Liver Neoplasms / Q000175:diagnosis / Q000821:virology; D014761:Viral Hepatitis Vaccines / Q000627:therapeutic use
chemical_list: D000998:Antiviral Agents; D014761:Viral Hepatitis Vaccines